Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Filings indexed 674 across all filing types
Latest filing 2026-02-10 Capital/Financing Update
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Options to purchase securities
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the outcome of a Nomination and Remuneration Committee meeting. It details the grant of employee stock options under a specific Employee Stock Option Scheme (ESOS) for the year 2025. The content includes specifics about the number of options granted, exercise price, vesting period, and other terms related to the stock option scheme. It is a regulatory disclosure pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which mandates disclosure of material events. The document does not contain financial statements or comprehensive financial data but is an announcement of a corporate action related to employee stock options. This fits the category of Capital/Financing Update (CAP), as it relates to changes in capital structure through stock options granted to employees.
2026-02-10 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the outcome of a Nomination and Remuneration Committee meeting. It details the grant of employee stock options under a specific Employee Stock Option Scheme (ESOS) for the year 2025. The content includes specifics about the number of options granted, exercise price, vesting period, and other terms related to the stock option grant. There is no financial statement or comprehensive financial data presented, nor is this a report or presentation. The document is a regulatory announcement about a corporate action related to employee stock options, which fits the category of Capital/Financing Update (CAP) as it pertains to changes in capital structure through stock option grants. The document length is about 5934 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-02-10 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the scheduling of a Board of Directors meeting to consider and approve the Un-Audited Financial Results for the quarter and nine months ended December 31, 2025. It references regulatory compliance under SEBI LODR Regulations and insider trading regulations. The document does not contain the financial results themselves but announces the upcoming approval and release of these results. The document length is short (1837 characters) and serves as an intimation or announcement rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about an upcoming report, not the report itself.
2026-02-04 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the outcome of a Board of Directors meeting. It details the allotment of equity shares consequent to the conversion of fully convertible warrants issued on a preferential basis. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and provides specifics about the number of shares allotted, issue price, and post-allotment share capital. It also includes an annexure with detailed disclosures as required under SEBI regulations. The content focuses on a capital structure change through preferential allotment and conversion of warrants, which is a financing activity. The document is not a full financial report, earnings release, or management discussion but an update on capital/financing activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (5806 characters) and detailed content support this classification with high confidence.
2026-02-01 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of physical share certificates for the quarter ending December 31, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar & share transfer agent. The content is a compliance certificate related to share dematerialization and does not contain financial statements, management discussion, or detailed report data. The document length is short (2483 characters) and it serves as a regulatory compliance filing rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory announcements.
2026-01-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.